In the past years, cardiac mortality has decreased, but cardiac diseases are still responsible for millions of deaths every year worldwide. Bone-marrow mesenchymal stem cells (BMSCs) transplantation may be a promising therapeutic strategy because of its capacity to differentiate into cardiac cells. Current research indicates that chemical substances, microRNAs, and cytokines have biological functions that regulate the cardiomyocytes differentiation of BMSCs. In this review, we chiefly summarize the regulatory factors that induce BMSCs to differentiate into cardiomyocytes.
CITATION STYLE
Guo, X., Bai, Y., Zhang, L., Zhang, B., Zagidullin, N., Carvalho, K., … Cai, B. (2018, February 26). Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: New regulators and its implications. Stem Cell Research and Therapy. BioMed Central Ltd. https://doi.org/10.1186/s13287-018-0773-9
Mendeley helps you to discover research relevant for your work.